Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2022, Vol. 36 ›› Issue (3): 98-103.doi: 10.6040/j.issn.1673-3770.0.2020.428

Previous Articles     Next Articles

Application status of oral corticosteroids during the perioperative period of chronic rhinosinusitis with nasal polyps

ZI HaokunOverview,XIAO Xuping, LI Yunqiu   

  1. Department of Otorhinolaryngology & Head and Neck Surgery, the First Affiliated Hospital of Hunan Normal University/Hunan Provincial People's Hospital, Changsha 410005, Hunan, China
  • Published:2022-06-15

PDF (PC)

739

Abstract: Endoscopic sinus surgery (ESS) has become the “gold standard” for the surgical treatment of chronic rhinosinusitis with nasal polyps (CRSwNP). The perioperative management of ESS has an important influence on the results of surgery. At present, oral glucocorticoids have been used as ESS perioperative adjuvant drugs to enhance the surgical effect due to their antiinflammatory and immunosuppressive effects. However, there are still controversies related to their dosage form and efficacy. This article reviews the recent studies on oral glucocorticoids and CRSwNPrelated literature on perioperative efficacy. The effects and treatment strategies of oral glucocorticoids during the perioperative period have been reviewed to provide more treatment options and research directions.

CLC Number: 

  • R765
[1] Fokkens WJ, Lund VJ, Hopkins C, et al.European position paper on rhinosinusitis and nasal polyps 2020[J]. Rhinology, 2020, 58(S29):1-464. doi: 10.4193/Rhin20.600.
[2] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国慢性鼻窦炎诊断和治疗指南(2018)[J]. 中华耳鼻咽喉头颈外科杂志, 2019, 54(2): 81-100. doi:10.3760/cma.j.issn.1673-0860.2019.02.001. Chinese guidelines for diagnosis and treatment of chronic rhinosinusitis(2018)[J]. Chin J Otorhinolaryngol Head Neck Surg, 2019, 54(2): 81-100. doi:10.3760/cma.j.issn.1673-0860.2019.02.001.
[3] 付清玲, 史剑波. 我国慢性鼻-鼻窦炎的流行病学特征及其伴随疾病和危险因素解析[J]. 临床耳鼻咽喉头颈外科杂志, 2018, 32(5): 321-324. doi:10.13201/j.issn.1001-1781.2018.05.001. FU Qingling, SHI Jianbo. Epidemiology, occupational and environmental risk factors of chronic rhinosinusitis in China[J]. J Clin Otorhinolaryngol Head Neck Surg, 2018, 32(5): 321-324. doi:10.13201/j.issn.1001-1781.2018.05.001.
[4] Albu S, Tomescu E. Small and large middle meatus antrostomies in the treatment of chronic maxillary sinusitis[J]. Otolaryngol Head Neck Surg, 2004, 131(4): 542-547. doi:10.1016/j.otohns.2004.02.045.
[5] Wright ED, Agrawal S. Impact of perioperative systemic steroids on surgical outcomes in patients with chronic rhinosinusitis with polyposis: evaluation with the novel Perioperative Sinus Endoscopy(POSE)scoring system[J]. Laryngoscope, 2007, 117(11 Pt 2 Suppl 115): 1-28. doi:10.1097/MLG.0b013e31814842f8.
[6] Pundir V, Pundir J, Lancaster G, et al. Role of corticosteroids in Functional Endoscopic Sinus Surgery: a systematic review and meta-analysis[J]. Rhinology, 2016, 54(1): 3-19. doi:10.4193/Rhin15.079.
[7] Shen KH, Wang YH, Hsu TW, et al. Differential effects of postoperative oral corticosteroid on eosinophilic vs. non-eosinophilic CRSwNP subtypes[J]. Am J Otolaryngol, 2019, 40(1): 22-29. doi:10.1016/j.amjoto.2018.09.005.
[8] 张罗, 强华, 王振刚, 等. 口服糖皮质激素治疗慢性鼻-鼻窦炎[J]. 中华耳鼻咽喉头颈外科杂志, 2013, 48(2): 100-102. doi:10.3760/cma.j.issn.1673-0860.2013.02.006.
[9] Campbell RG. Risks and management of long-term corticosteroid use in chronic rhinosinusitis[J]. Curr Opin Otolaryngol Head Neck Surg, 2018, 26(1): 1-7. doi:10.1097/moo.0000000000000421.
[10] Richards RN. Side effects of short-term oral corticosteroids[J]. J Cutan Med Surg, 2008, 12(2): 77-81. doi:10.2310/7750.2008.07029.
[11] Stevens WW, Schleimer RP, Kern RC. Chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol Pract, 2016, 4(4): 565-572. doi:10.1016/j.jaip.2016.04.012.
[12] Head K, Chong LY, Hopkins C, et al. Short-course oral steroids alone for chronic rhinosinusitis[J]. Cochrane Database Syst Rev, 2016, 4: CD011991. doi:10.1002/14651858.CD011991.pub2.
[13] Karatzanis A, Chatzidakis A, Milioni A, et al. Contemporary use of corticosteroids in rhinology[J]. Curr Allergy Asthma Rep, 2017, 17(2): 11. doi:10.1007/s11882-017-0679-0.
[14] Younis RT, Ahmed J. Predicting revision sinus surgery in allergic fungal and eosinophilic mucin chronic rhinosinusitis[J]. Laryngoscope, 2017, 127(1): 59-63. doi:10.1002/lary.26248.
[15] Alobid I, Benítez P, Cardelús S, et al. Oral plus nasal corticosteroids improve smell, nasal congestion, and inflammation in Sino-nasal polyposis[J]. Laryngoscope, 2014, 124(1): 50-56. doi:10.1002/lary.24330.
[16] Byun SH, Min CY, Park IS, et al. Increased risk of chronic periodontitis in chronic rhinosinusitis patients: a longitudinal follow-up study using a national health-screening cohort[J]. J Clin Med,2020, 9(4): 1170. doi:10.3390/jcm9041170.
[17] Ramakrishnan VR. Ergonomics in endoscopic sinus surgery[J]. Curr Opin Otolaryngol Head Neck Surg, 2019, 27(1): 25-28. doi:10.1097/MOO.0000000000000504.
[18] Ecevit MC, Erdag TK, Dogan E, et al. Effect of steroids for nasal polyposis surgery: a placebo-controlled, randomized, double-blind study[J]. Laryngoscope, 2015, 125(9): 2041-2045. doi:10.1002/lary.25352.
[19] 张思远, 曹志伟. 口服糖皮质激素治疗慢性鼻-鼻窦炎伴鼻息肉[J]. 国际耳鼻咽喉头颈外科杂志, 2019, 43(4): 234-237. doi:10.3760/cma.j.issn.1673-4106.2019.04.012. ZHANG Siyuan, CAO Zhiwei. Oral glucocorticoids for chronic rhinosinusitis with nasal polyps[J]. Int J Dermatol Venereol, 2019, 43(4): 234-237. doi:10.3760/cma.j.issn.1673-4106.2019.04.012.
[20] de Borja Callejas F, Martínez-Antón A, Picado C, et al. Corticosteroid treatment regulates mucosal remodeling in chronic rhinosinusitis with nasal polyps[J]. Laryngoscope, 2015, 125(5):E158-67. doi: 10.1002/lary.25147.
[21] Hwang SH, Seo JH, Joo YH, et al. Does the preoperative administration of steroids reduce intraoperative bleeding during endoscopic surgery of nasal polyps?[J]. Otolaryngol Head Neck Surg, 2016, 155(6): 949-955. doi:10.1177/0194599816663455.
[22] Dautremont JF, Mechor B, Rudmik L. The role of immediate postoperative systemic corticosteroids when utilizing a steroid-eluting spacer following sinus surgery[J]. Otolaryngol Head Neck Surg, 2014, 150(4): 689-695. doi:10.1177/0194599814521373.
[23] Wu X, Hong H, Zuo K, et al. Expression of leukotriene and its receptors in eosinophilic chronic rhinosinusitis with nasal polyps[J]. Int Forum Allergy Rhinol, 2016, 6(1): 75-81. doi:10.1002/alr.21625.
[24] 张宇, 宋西成. 慢性鼻窦炎伴鼻息肉与哮喘的相关性机制及治疗策略研究进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 49-52. doi:10.6040/j.issn.1673-3770.1.2018.033. ZHANG Yu, SONG Xicheng. Advances in interaction mechanisms and treatment strategy between chronic rhinosinusitis with nasal polyp and asthma[J]. J Otolaryngol Ophthalmol Shandong Univ, 2019, 33(1): 49-52. doi:10.6040/j.issn.1673-3770.1.2018.033.
[25] 陶丹丹, 董红军, 褚云锋, 等. 慢性鼻-鼻窦炎伴鼻息肉患者组织嗜酸性粒细胞与嗅觉功能障碍的相关性研究[J]. 山东大学耳鼻喉眼学报, 2020, 34(6): 16-20. doi:10.6040/j.issn.1673-3770.0.2019.388. TAO Dandan, DONG Hongjun, CHU Yunfeng, et al. Correlation between eosinophils and olfactory dysfunction in patients with CRSwNP after nasal operation[J]. J Otolaryngol Ophthalmol Shandong Univ, 2020, 34(6): 16-20. doi:10.6040/j.issn.1673-3770.0.2019.388.
[26] 娄鸿飞, 王成硕. 慢性鼻窦炎分型研究进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 10-13. doi:10.6040/j.issn.1673-3770.1.2018.008. LOU Hongfei, WANG Chengshuo. Progress in classification of chronic sinusitis[J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(3): 10-13. doi:10.6040/j.issn.1673-3770.1.2018.008.
[27] Akiyama K, Makihara S, Uraguchi K, et al. Impact of preoperative systemic corticosteroids on the histology and diagnosis of eosinophilic chronic rhinosinusitis[J]. Int Arch Allergy Immunol, 2019, 179(2): 81-88. doi:10.1159/000496437.
[28] Stevens WW, Ocampo CJ, Berdnikovs S, et al. Cytokines in chronic rhinosinusitis. role in eosinophilia and aspirin-exacerbated respiratory disease[J]. Am J Respir Crit Care Med, 2015, 192(6): 682-694. doi:10.1164/rccm.201412-2278OC.
[29] de Rosati D, Rosato C, Pagliuca G, et al. Predictive markers of long-term recurrence in chronic rhinosinusitis with nasal polyps[J]. Am J Otolaryngol, 2020, 41(1): 102286. doi:10.1016/j.amjoto.2019.102286.
[30] Ghogomu N, Kern R. Chronic rhinosinusitis: the rationale for current treatments[J]. Expert Rev Clin Immunol, 2017, 13(3): 259-270. doi:10.1080/1744666X.2016.1220833.
[31] 戴飞, 魏瑾瑾, 汤欣玥, 等. 2-APB体外抑制嗜中性粒细胞型鼻息肉中的炎症反应[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 97-100. doi:10.6040/j.issn.1673-3770.0.2019.413. DAI Fei, WEI Jinjin, TANG Xinyue, et al. 2-aminoethoxydiphenyl borate inhibits inflammatory reactions of neutrophilic nasal polyps in vitro[J]. J Otolaryngol Ophthalmol Shandong Univ, 2020, 34(4): 97-100. doi:10.6040/j.issn.1673-3770.0.2019.413.
[32] Wen WP, Liu WL, Zhang L, et al. Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy[J]. J Allergy Clin Immunol, 2012, 129(6): 1522-1528.e5. doi:10.1016/j.jaci.2012.01.079.
[33] Wang W, Gao Y, Zhu Z, et al. Changes in the clinical and histological characteristics of Chinese chronic rhinosinusitis with nasal polyps over 11 years[J]. Int Forum Allergy Rhinol, 2019, 9(2): 149-157. doi:10.1002/alr.22234.
[34] Wang XD, Zhang N, Bo MY, et al. Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania[J]. J Allergy Clin Immunol, 2016, 138(5): 1344-1353. doi:10.1016/j.jaci.2016.05.041.
[35] Fujieda S, Imoto Y, Kato Y, et al. Eosinophilic chronic rhinosinusitis[J]. Allergol Int, 2019,68(4):403-412. doi: 10.1016/j.alit.2019.07.002.
[36] Fokkens WJ, Lund V, Bachert C, et al. EUFOREA consensus on biologics for CRSwNP with or without asthma[J]. Allergy, 2019, 74(12): 2312-2319. doi:10.1111/all.13875.
[1] ZHU Jiang, LIU Taixiang, JIANG Bing. Changes in conjunctival sac microbiota before and after endoscopic dacryocystorhinostomy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 13-20.
[2] LYU Qian, TANG Yuan, GU Zijun, SHI Sailei, LIU Ping, WAN Wenjin. Current status of benefit finding among patients with allergic rhinitis and its influence factors [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 21-28.
[3] GUO Rongchang, LIU Qinghang, WANG Hongzeng, SUN Shujun. Through the orbit with sinus huge foreign bodies embedded in the base of the skull: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 135-141.
[4] ZHANG Yongcai, ZHANG Jiang, LU Hui, XING Kexin, WU Jingfang, XUE Gang, LI Yanping, LIU Yanbin. Expression and significance of CXCL10 and IFN-γ in antrochoanal polyp [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 7-12.
[5] SU Riguge, LI Hua, WU Richaifu, HAN Eerdemutu, MENG Yongmei. Elucidation of the Mongolian medicine Huricha-6 mechanism in treating allergic rhinitis via network pharmacology and animal experiments [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 41-51.
[6] LI Xia, HOU Ran, WANG Liping. Bibliometric analysis based on Web of Science for nasal irrigation for nasal diseases in the last decade [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 52-60.
[7] LIU Jiaxin, JIANG Ye, SONG Daoliang. Endoscopic transnasal fenestration for maxillary bone cysts: a report of nine cases and a review of the literature [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 84-88.
[8] YAN Huijuan, XIAO Xuping, ZHONG Yu. Expression and clinical significance of IL-29 and TLR4 in eosinophil infiltrated nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 122-127.
[9] CHENG Xiqiao, QU Shenhong. Application and progress of three-dimensional-printing technology in rhinology [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 128-136.
[10] LIU Bo, XIAO Xuping, LI Yunqiu, ZHOU En, GUO Renbin. Bilateral ossification of the auricular cartilage: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(4): 12-16.
[11] LI Dan, CHEN Tengyu, HUANG Yanfen, ZHOU Min, ZHOU Yixing, RUAN Yan, YAN Yajie. Research in the field of olfactory disorders in China—An analysis based on Citespace [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(4): 40-48.
[12] LU Xiaoyan, WEN Shuxin. Advances in the treatment of congenital choanal atresia [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(1): 138-142.
[13] YUAN Chenyang, LIU Yan, FANG Zhensheng. Advances on the effect of OSAHS on pulmonary function in children [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(1): 143-148.
[14] Central retinal artery occlusion(CRAO)is the most common cause of acute vision loss. Thrombolysis is a more radical treatment than conservative treatment, including arterial thrombolysis and intravenous thrombolysis, as well as the combination therapy of thrombolysis and other therapies. Thrombolysis treatment can improve the visual acuity of CRAO patients, but because of its lack of randomized controlled trials, further clinical studies are needed to determine their efficacy and safety. Our review summarized the application progress of thrombolysis in recent ten years, further evaluated its safety and effectiveness, and provided an evidence for clinical application.. Application progress of thrombolysis in retinal artery occlusionYANG Ming Overview WEI Wenbin Guidance Beijing Tongren Hospital, Capital Medical University / Beijing Tongren Eye Center / Beijing key Laboratory of Intraocular Tumor Diagnosis and Treatment / Beijing Ophthalmology&Visual Sciences Key Lab / Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing 100730, ChinaAbstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 5-10.
[15] ObjectiveTo discuss the early diagnosis and multidisciplinary diagnosis and treatment of neovascular glaucoma in ocular ischemic syndrome. MethodsThe medical records of a 54-year-old male patient with cerebral infarction who presented with right-eye vision loss that had persisted for a week were reviewed. After slit-lamp examination and fluorescence angiography, he was diagnosed with ocular ischemic syndrome(OIS)complicated by neovascular glaucoma in the right eye and treated with intravitreal injection of anti-VEGF drugs and panretinal photocoagulation. ResultsAfter three months of treatment, the right-eye iris neovascularization subsided, and the intraocular pressure was controlled within normal limits. ConclusionOcular ischemia is often missed or misdiagnosed by ophthalmologists, neurologists, cardiologists, and vascular surgeons due to its insidious onset and complex clinical manifestations. Therefore, the establishment of multidisciplinary diagnosis and treatment can improve the prognosis of OIS patients.. Neovascular glaucoma in ocular ischemic syndrome: a case report and literature reviewQIN Shuqi1, WANG Luping1, JIANG Bin2, WANG Yanling1 1. Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 10050, China; 2. Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 10050, ChinaAbstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 53-55.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd